Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk.
Tsilika M, Taks E, Dolianitis K, Kotsaki A, Leventogiannis K, Damoulari C, Kostoula M, Paneta M, Adamis G, Papanikolaou I, Stamatelopoulos K, Bolanou A, Katsaros K, Delavinia C, Perdios I, Pandi A, Tsiakos K, Proios N, Kalogianni E, Delis I, Skliros E, Akinosoglou K, Perdikouli A, Poulakou G, Milionis H, Athanassopoulou E, Kalpaki E, Efstratiou L, Perraki V, Papadopoulos A, Netea MG, Giamarellos-Bourboulis EJ. Tsilika M, et al. Among authors: kalogianni e. Front Immunol. 2022 Jul 5;13:873067. doi: 10.3389/fimmu.2022.873067. eCollection 2022. Front Immunol. 2022. PMID: 35865520 Free PMC article. Clinical Trial.
Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk.
Tsilika M, Taks E, Dolianitis K, Kotsaki A, Leventogiannis K, Damoulari C, Kostoula M, Paneta M, Adamis G, Papanikolaou I, Stamatelopoulos K, Bolanou A, Katsaros K, Delavinia C, Perdios I, Pandi A, Tsiakos K, Proios N, Kalogianni E, Delis I, Skliros E, Akinosoglou K, Perdikouli A, Poulakou G, Milionis H, Athanassopoulou E, Kalpaki E, Efstratiou L, Perraki V, Papadopoulos A, Netea MG, Giamarellos-Bourboulis EJ. Tsilika M, et al. Among authors: kalogianni e. Front Immunol. 2022 Aug 31;13:1018384. doi: 10.3389/fimmu.2022.1018384. eCollection 2022. Front Immunol. 2022. PMID: 36119100 Free PMC article.
Myocardial fibrosis after COVID-19 infection and severe sinus arrest episodes in an asymptomatic patient with mild sleep apnea syndrome: A case report and review of the literature.
Lampropoulos CE, Mavrogeni S, Dervas A, Manios E, Chatzidou S, Kontogiannis C, Spiliopoulou S, Melliou S, Kalogianni E, Papaioannou I. Lampropoulos CE, et al. Among authors: kalogianni e. Respir Med Case Rep. 2021;32:101366. doi: 10.1016/j.rmcr.2021.101366. Epub 2021 Feb 17. Respir Med Case Rep. 2021. PMID: 33619450 Free PMC article.
Fabrication of hollow microneedles using liquid crystal display (LCD) vat polymerization 3D printing technology for transdermal macromolecular delivery.
Xenikakis I, Tsongas K, Tzimtzimis EK, Zacharis CK, Theodoroula N, Kalogianni EP, Demiri E, Vizirianakis IS, Tzetzis D, Fatouros DG. Xenikakis I, et al. Among authors: kalogianni ep. Int J Pharm. 2021 Mar 15;597:120303. doi: 10.1016/j.ijpharm.2021.120303. Epub 2021 Feb 2. Int J Pharm. 2021. PMID: 33540009
Priority and emerging organic microcontaminants in three Mediterranean river basins: Occurrence, spatial distribution, and identification of river basin specific pollutants.
Köck-Schulmeyer M, Ginebreda A, Petrovic M, Giulivo M, Aznar-Alemany Ò, Eljarrat E, Valle-Sistac J, Molins-Delgado D, Diaz-Cruz MS, Monllor-Alcaraz LS, Guillem-Argiles N, Martínez E, Miren LA, Llorca M, Farré M, Peña JM, Mandaric L, Pérez S, Majone B, Bellin A, Kalogianni E, Skoulikidis NT, Milačič R, Barceló D. Köck-Schulmeyer M, et al. Among authors: kalogianni e. Sci Total Environ. 2021 Feb 1;754:142344. doi: 10.1016/j.scitotenv.2020.142344. Epub 2020 Sep 17. Sci Total Environ. 2021. PMID: 33254885
52 results